Report cover image

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

Published Oct 31, 2022
Length 348 Pages
SKU # KLI17489187

Description

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies.

This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three countries is over 310 million, which is close to the population in the United States.

Among these three countries, Singapore has established world class healthcare service capabilities in terms of infrastructure as well as skilled manpower. Though the population is less than 6 million, the Singapore market is attractive for IVD companies and it has become a medical tourism hub in the region. Indonesia, on the other hand, is a country with a huge population of about 275 million people. The country is taking significant steps to improve its healthcare infrastructure, which is offering considerable opportunities for IVD companies. The Malaysian market, with a population of about 32 million falls in between these two countries, both in terms of healthcare service capabilities and growth potentials.

In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:
  • POC
  • Clinical Chemistry
  • Immunoassays
  • Molecular Assays
  • Hematology
  • Coagulation
  • Microbiology and Virology
  • Blood Testing and Typing
  • Histology and Cytology
The report also profiles key companies in the market:
  • Abbott Diagnostics
  • ARKRAY
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson, and Company (BD)
  • BioCytech Corporation
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Caris Life Sciences
  • Cephei
  • CTK Biotech Inc
  • Danaher Corporation
  • Dexcom
  • DiaSorin S.p.A
  • Grifols S.A.
  • Healgen Scientific LLC
  • Hologic, Inc.
  • Horiba Medical
  • Lucence Diagnostics
  • Medical Innovation Ventures Sdn. Bhd. (Mediven)
  • Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)
  • MiRXES Pte Ltd.
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics (Ortho)
  • PerkinElmer, Inc. (PE)
  • QIAGEN
  • Reszon Diagnostics International
  • Roche Diagnostics
  • Sysmex Corporation
  • Vela Diagnostics
  • Veredus Laboratories Pte Ltd

Table of Contents

348 Pages
    • Malaysia: Healthcare and Regulatory Landscape
    • IVD Market Size Estimation and Forecast for Malaysia
    • Indonesia: Healthcare and Regulatory Landscape
    • IVD Market Size Estimation and Forecast for Indonesia
    • Singapore: Healthcare and Regulatory Landscape
    • IVD Market Size Estimation and Forecast for Singapore
    • The Combined IVD Markets of Malaysia, Indonesia, and Singapore
    • COVID-19 Testing Trends in Malaysia (2020-2022)
    • COVID-19 Testing Trends in Indonesia (2020-2022)
    • COVID-19 Testing Trends in Singapore (2020-2022)
    • Pregnancy and Fertility Testing
    • Cancer Testing
    • Lipid Testing
    • Drug of Abuse (DOA) Testing
    • Infectious Disease Testing
    • Diabetes Testing – Blood Glucose Monitoring
    • Other POC tests
    • Workstation Consolidation and Laboratory Automation
    • Core Lab: Market Analysis
    • Clinical Chemistry Market Analysis
    • Cardiac Markers
    • Tumor Markers
    • Diabetes
    • Thyroid
    • Autoimmune Diseases
    • Other Immunoassay Segments
    • Oncology
    • Genetic Diseases and Disorders
    • Transplant Diagnostics
    • Laboratory-based Hematology: Technology and Market Trends
    • Impact of COVID-19
    • Lab-based Coagulation Testing
    • Antibiotic Resistant Infections: Challenges and Solutions
    • Syndromic Testing
    • Diagnosis of Prevalent Infectious Diseases in Malaysia, Indonesia, and Singapore
    • Clinical Microbiology and Virology Market Segments
    • ID/AST: Market Analysis
    • Microbiology Immunoassays
    • Molecular Microbiology (Laboratory-based)
    • Blood Typing and Grouping
    • Blood Banking Service Markets in Malaysia
    • Blood Banking Service Markets in Indonesia
    • Blood Banking Service Markets in Singapore
    • HPV Testing: A Fast-Growing Market Segment
    • Technological Advancements in Histology and Cytology
    • Market Trends
    • Histology and Cytology Markets in Malaysia
    • Histology and Cytology Markets in Indonesia
    • Histology and Cytology Markets in Singapore
    • The Top Tier IVD Companies in Malaysia, Indonesia, and Singapore
    • Company Profiles: The Second Tier - Multinationals, Regional Companies, etc.
    • IVD Distributors in Malaysia, Indonesia, and Singapore
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.